|
gptkbp:instanceOf
|
gptkb:psychedelic_phenethylamine
|
|
gptkbp:belongs_to_class
|
gptkb:2C_family
|
|
gptkbp:CASNumber
|
207740-25-8
|
|
gptkbp:chemicalFormula
|
C13H21NO2
|
|
gptkbp:color
|
white
|
|
gptkbp:discoveredBy
|
gptkb:Alexander_Shulgin
|
|
gptkbp:duration_of_effects
|
10-20 hours
|
|
gptkbp:effect
|
euphoria
hallucinations
altered perception
|
|
gptkbp:firstSynthesized
|
1974
|
|
gptkbp:hasSMILES
|
CCCNc1cc(OC)cc(OC)c1
|
|
gptkbp:hasStreet
|
gptkb:2C-P
|
|
gptkbp:IUPACName
|
2-(4-propyl-2,5-dimethoxyphenyl)ethanamine
|
|
gptkbp:legalStatus
|
gptkb:Schedule_III_(Canada)
gptkb:Class_A_(UK)
Schedule I (USA)
|
|
gptkbp:meltingPoint
|
151-152°C
|
|
gptkbp:molecularWeight
|
223.31 g/mol
|
|
gptkbp:PubChem_CID
|
4527137
|
|
gptkbp:publishedIn
|
gptkb:PiHKAL
|
|
gptkbp:relatedTo
|
gptkb:2C-T-7
gptkb:2C-E
gptkb:2C-B
|
|
gptkbp:routeOfAdministration
|
oral
insufflation
|
|
gptkbp:solubility
|
soluble in water
|
|
gptkbp:toxicity
|
not well studied
|
|
gptkbp:UNII
|
2ZK1V6F2F6
|
|
gptkbp:bfsParent
|
gptkb:NBOMe_series
gptkb:2C_family
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
2C-P
|